Seanergy Dermatology
Therapeutics for Atopic Dermatitis, Psoriasis, and Other Inflammatory Conditions
StartupSeanergy Dermatology is a Rehovot-based startup in the Health Tech & Life Sciences sector, established in 2018. Therapeutics for Atopic Dermatitis, Psoriasis, and Other Inflammatory Conditions. Seanergy Dermatology was founded by Eran Perry, Masanobu Ogawa, Doron Friedman. Key investors include Maruho Israel Innovation Fund. The company has 1-10 employees. Core technologies: Biologicals, Microorganisms.
The company follows a B2B business model. Product stage: Clinical Trial. The company holds 1 patent.
- StageSeed
- ProductClinical Trial
- ModelB2B
- Employees1-10
- HQRehovot
- DistrictCenter District
- Last RoundUndisclosed
- Maruho Israel Innovation Fund
Eran PerryCo-founder 
Masanobu OgawaCo-founder 
Doron FriedmanCo-founder
What does Seanergy Dermatology do?
Seanergy is a clinical stage pharmaceutical company developing a new category of topical therapeutics for treatment of inflammatory and other skin conditions. Its patented technology is based on the discovery of a synergistic mechanism between anti-inflammatory APIs and Sulphated Polysaccharides extracted from algae.
Who founded Seanergy Dermatology?
Seanergy Dermatology was founded in 2018 by Eran Perry (Co-founder ), Masanobu Ogawa (Co-founder ), Doron Friedman (Co-founder ).
What sector is Seanergy Dermatology in?
Seanergy Dermatology operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Drugs Discovery & Development, with core technologies in Biologicals, Microorganisms. Target customers: Healthcare & Life Sciences, Life Sciences, Pharmaceuticals.
Where is Seanergy Dermatology located?
Seanergy Dermatology is based in Yitzhak Modai St 2, Rehovot, Israel, Center District.